Innovation Pharmaceuticals Inc. (11)

Browse by Contract Category

Contracts

Series A Preferred Share Purchase Agreement, dated June 9, 2022, by and among Squalus Med Ltd. and Innovation Pharmaceuticals Inc (Filed With SEC on June 15, 2022)
Amendments to the Innovation Pharmaceuticals Inc. 2016 Equity Incentive Plan, as amended (Filed With SEC on October 14, 2021)
Exclusive License Agreement, dated July 18, 2019, between Innovation Pharmaceuticals Inc. and Alfasigma S.p.A (Filed With SEC on July 22, 2019)
Securities Purchase Agreement, dated December 9, 2020, between the Company and the investor party thereto (Filed With SEC on December 10, 2020)
Form of Warrant (Filed With SEC on December 10, 2020)
Common Stock Purchase Agreement, dated July 31, 2020, between Innovation Pharmaceuticals Inc. and Aspire Capital Fund, LLC (Filed With SEC on August 4, 2020)
Registration Rights Agreement, dated July 31, 2020, between Innovation Pharmaceuticals Inc. and Aspire Capital Fund, LLC (Filed With SEC on August 4, 2020)
Form of Warrant Amendment Agreement, dated December 26, 2019, between the Company and each investor party thereto (Filed With SEC on December 26, 2019)
Description of Class A common stock (Filed With SEC on September 30, 2019)
Form of Series 4 Warrant (Filed With SEC on May 10, 2019)
Form of Warrant Restructuring and Additional Issuance Agreement, dated May 9, 2019, between the Company and the investors party thereto (Filed With SEC on May 10, 2019)